U.S. markets closed
  • S&P Futures

    4,573.00
    +1.75 (+0.04%)
     
  • Dow Futures

    35,301.00
    +42.00 (+0.12%)
     
  • Nasdaq Futures

    15,200.00
    -6.00 (-0.04%)
     
  • Russell 2000 Futures

    2,093.70
    +1.60 (+0.08%)
     
  • Crude Oil

    87.02
    +1.59 (+1.86%)
     
  • Gold

    1,812.50
    +0.10 (+0.01%)
     
  • Silver

    23.49
    -0.00 (-0.01%)
     
  • EUR/USD

    1.1330
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.8650
    +0.0930 (+5.25%)
     
  • Vix

    22.79
    +3.60 (+18.76%)
     
  • GBP/USD

    1.3600
    +0.0002 (+0.01%)
     
  • USD/JPY

    114.6720
    +0.0870 (+0.08%)
     
  • BTC-USD

    42,420.85
    +205.20 (+0.49%)
     
  • CMC Crypto 200

    1,010.93
    +1.54 (+0.15%)
     
  • FTSE 100

    7,563.55
    -47.68 (-0.63%)
     
  • Nikkei 225

    27,730.59
    -526.66 (-1.86%)
     

60 Biggest Movers From Friday

  • Oops!
    Something went wrong.
    Please try again later.
·8 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Gainers

  • IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.

  • Echo Global Logistics, Inc. (NASDAQ: ECHO) gained 52.3% to settle at $47.70 after the company agreed to be acquired by private equity firm The Jordan Company.

  • Affirm Holdings, Inc. (NASDAQ: AFRM) jumped 34.4% to settle at $123.70 after the company reported better-than-expected Q4 sales and issued strong Q1 sales guidance.

  • Farmmi, Inc. (NASDAQ: FAMI) jumped 34.4% to close at $0.5750. Farmmi’s subsidiary Zhejiang Forest Food Co Ltd recently won a new product order for its dried whole Shiitake mushrooms.

  • Endo International plc (NASDAQ: ENDP) shares rose 32.9% to close at $2.79 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.

  • SigmaTron International, Inc. (NASDAQ: SGMA) gained 32.6% to settle at $8.30 after the company announced its first-quarter fiscal 2022 financial results.

  • Onion Global Limited (NYSE: OG) surged 26.2% to close at $6.79. Onion Global, last month, reported $107.90 million in sales this quarter.

  • IronNet, Inc. (NASDAQ: IRNT) jumped 24.6% to settle at $21.57.

  • T2 Biosystems, Inc. (NASDAQ: TTOO) climbed 23.5% to close at $1.07 after the company announced its T2SARS-CoV-2 panel proved capable of detecting the Mu B.1.621 and Iota B.1.526 variants of the SARS-CoV-2 virus.

  • Research Frontiers Incorporated (NASDAQ: REFR) gained 21.5% to settle at $2.88.

  • Elite Education Group International Limited (NASDAQ: EEIQ) jumped 20.9% to close at $6.31 after jumping 20% on Thursday.

  • Greenlane Holdings, Inc. (NASDAQ: GNLN) climbed 18.4% to close at $3.02.

  • Euroseas Ltd. (NASDAQ: ESEA) gained 18.2% to settle at $30.72. Euroseas, last week, announced a new time charter contract for its container vessel M/V Synergy Oakland.

  • Camber Energy, Inc. (NYSE: CEI) shares jumped 16.9% to close at $1.52 after jumping 31% on Thursday.

  • Aterian, Inc. (NASDAQ: ATER) climbed 15.9% to close at $11.80.

  • Vince Holding Corp. (NYSE: VNCE) gained 15.5% to close at $7.75 after the company reported better-than-expected Q2 results.

  • Rubicon Technology, Inc. (NASDAQ: RBCN) rose 15.2% to settle at $10.70.

  • Adagio Therapeutics, Inc. (NASDAQ: ADGI) gained 14.9% to close at $53.90. Adagio Therapeutics announced that the independent data monitoring committee (IDMC) has recommended expanding the ADG20 EVADE Phase 2/3 trial for COVID-19.

  • The Dixie Group, Inc. (NASDAQ: DXYN) climbed 14.8% to close at $5.11.

  • Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 13.2% to settle at $4.38 after gaining over 15% on Thursday.

  • PaySign, Inc. (NASDAQ: PAYS) climbed 12.9% to close at $3.32. PaySign shares climbed around 25% on Thursday following circulation of an earlier TipRanks article titled '3 "Strong Buy" Stocks Flirting With a Bottom' mentioning the stock.

  • National Beverage Corp. (NASDAQ: FIZZ) gained 12.3% to settle at $52.55after the company reported Q1 EPS and sales results were higher year over year.

  • SEMrush Holdings, Inc. (NYSE: SEMR) rose 12.1% to close at $31.32. Semrush named Andrew Warden as Chief Marketing Officer.

  • A-Mark Precious Metals, Inc. (NASDAQ: AMRK) gained 12% to settle at $58.29 following upbeat Q4 results.

  • Cedar Realty Trust, Inc. (NYSE: CDR) climbed 11.4% to close at $18.93 after the company reported dual-track review of strategic alternatives. The company also named Jennifer Bitterman Chief Financial Officer.

  • Spark Networks SE (NYSE: LOV) surged 11.3% to settle at $3.35.

  • CareMax, Inc. (NASDAQ: CMAX) gained 11% to close at $9.41. Cowen & Co. initiated coverage on CareMax with an Outperform rating and announced a price target of $14.

  • Lava Therapeutics B.V. (NASDAQ: LVTX) surged 10.8% to settle at $6.49.

  • NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) rose 9.9% to close at $23.36.

  • ironSource Ltd. (NYSE: IS) surged 9.8% to settle at $11.51.

  • CPI Card Group Inc. (NASDAQ: PMTS) gained 8.8% to close at $35.12.

  • UP Fintech Holding Limited (NASDAQ: TIGR) gained 8.6% to close at $14.53 after reporting Q2 results.

  • SOS Limited (NYSE: SOS) gained 8.5% to close at $2.80 after the company reported that revenue in the first half of 2021 totaled $184.5 million, representing an increase of 17 times year over year.

Check out these big penny stock gainers and losers

Losers

  • Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) fell 46.3% to close at $5.48 on Friday after climbing over 20% on Thursday.

  • Mersana Therapeutics, Inc. (NASDAQ: MRSN) dipped 39.1% to close at $8.56. Investors reacted to interim data from the ovarian cancer Phase 1 trial evaluating Upifitamab Rilsodotin (UpRi, previously XMT-1536).

  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) shares dipped 37.2% to close at $34.93 on Friday after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.

  • Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) dropped 25.6% to close at $11.60. Virpax Pharmaceuticals filed for offering of 3.4 million shares of common stock.

  • Impel NeuroPharma, Inc. (NASDAQ: IMPL) shares fell 23.8% to close at $16.11 after the company reported pricing of $45.0 million public offering.

  • Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) dropped 21.7% to settle at $7.58.

  • Support.com, Inc. (NASDAQ: SPRT) declined 19.3% to close at $21.00 after stockholders approved the merger with Greenidge Generation Holdings Inc.

  • Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT) fell 18.1% to settle at $7.89.

  • RLX Technology Inc. (NYSE: RLX) declined 16.8% to settle at $5.74.

  • Tuesday Morning Corporation (NASDAQ: TUEM) fell 16.7% to close at $1.95. Tuesday Morning shares fell 45% on Thursday after the company reported downbeat Q4 earnings.

  • RxSight, Inc. (NASDAQ: RXST) fell 16.1% to close at $13.42.

  • Immuneering Corporation (NASDAQ: IMRX) dropped 14.5% to settle at $20.75. Immuneering, last week, reported a Q2 loss of $1.61 per share.

  • Hippo Holdings Inc. (NYSE: HIPO) fell 14.4% to close at $5.87. The company earlier reported a Gross Loss Ratio of 161% for the three months ended June 30.

  • Xos, Inc. (NASDAQ: XOS) dropped 14.2% to settle at $7.17.

  • TMC the metals company Inc. (NASDAQ: TMC) fell 13.7% to settle at $9.41.

  • Humanigen, Inc.(NASDAQ: HGEN) dropped 13.7% to close at $6.88. Jefferies downgraded Humanigen from Buy to Hold and lowered the price target from $37 to $9.

  • SGOCO Group, Ltd. (NASDAQ: SGOC) declined 13.1% to settle at $6.18.

  • Lakeland Industries, Inc. (NASDAQ: LAKE) fell 13% to close at $20.80 after reporting downbeat Q2 sales.

  • Statera Biopharma, Inc. (NASDAQ: STAB) declined 12.9% to settle at $3.78.

  • Gevo, Inc. (NASDAQ: GEVO) declined 12.7% to close at $6.93. Gevo and Chevron, last week, announced a letter of intent to jointly invest in building and operating one or more new facilities that would process inedible corn to produce sustainable aviation fuel.

  • Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) shares dropped 11.8% to close at $47.08 after the company announced a 20 million share offering of Class A common stock by selling shareholders to be priced at $50 per share.

  • Spire Global, Inc. (NYSE: SPIR) declined 10.1% to close at $9.92.

  • Sumo Logic, Inc. (NASDAQ: SUMO) shares declined 9.5% to close at $18.21 after the company reported Q2 earnings results and issued Q3 guidance. Piper Sandler downgraded Sumo Logic from Overweight to Neutral and lowered the price target from $24 to $20.

  • Teradata Corporation (NYSE: TDC) fell 9.4% to close at $51.11. Several analysts raised their price targets on the stock.

  • PharmaCyte Biotech, Inc. (NASDAQ: PMCB) fell 9.1% to close at $3.59.

  • The Kroger Co. (NYSE: KR) fell 7.5% to close at $42.67despite reporting upbeat quarterly results.

  • Traeger, Inc. (NYSE: COOK) fell 6% to settle at $24.02 after the company reported Q2 earnings results.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.